Skip to content

RCT Comparing Conventional Haemorrhoidectomy With Laser Haemorrhoidoplasty

A Randomised Controlled Trial Comparing Conventional Open Haemorrhoidectomy and Laser Haemorrhoidoplasty in the Treatment of Symptomatic Haemorrhoids: COHLAH Trial

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04329364
Acronym
COHLAH
Enrollment
128
Registered
2020-04-01
Start date
2020-10-01
Completion date
2025-06-30
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoids

Keywords

haemorrhoid, laser, haemorrhoidectomy

Brief summary

Haemorrhoids or piles are the most common colorectal condition in the local population. Patients often present with bleeding with bowel movement or anal discomfort, both of which causes significant anxiety and stress. For symptomatic sizeable piles, the treatment of choice still remains the conventional open excision (COH). However, this technique carries with it a significant risk of bleeding and pain immediately after the operation, leading to some period of discomfort for the patients. The laser haemorrhoidoplasty procedure (LAH) has been shown in preliminary studies to have less pain, and less complications compared to COH. This study aims to directly compare these two techniques in a local Asian population. The investigators would be conducting a single-centre RCT simultaneously comparing the conventional open Milligan-Morgan haemorrhoidectomy (COH) and the laser haemorrhoidoplasty procedure (LAH) for the treatment of symptomatic grade ll-lV haemorrhoids. Primary outcomes will be post-operative pain while secondary outcomes include post-operative bleeding, readmission and/or reoperations, haemorrhoid-related quality of life (QoL) results and recurrence of symptoms up to a year post procedure

Interventions

COMBINATION_PRODUCTLaser Haemorrhoidoplasty (LAH)

Using a laser diode to cause coagulative necrosis to the haemorrhoidal cushion

PROCEDUREOpen milligan-morgan conventional haemorrhoidectomy

conventional excisional haemorrhoidectomy

Sponsors

Biolitec
CollaboratorUNKNOWN
Sengkang General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Allocation is provided through calling the study administrator at time of Examination under Anaesthesia. Thus, the participant is blinded to the procedure. There will also be no cross-over from one study arm to another. An independent research administrator, not part of the randomisation process, will also contact the patient 3 months and 1 year after the procedure as mentioned above.

Intervention model description

The investigators would be conducting a single-centre RCT simultaneously comparing the conventional open Milligan-Morgan haemorrhoidectomy (COH) and the laser haemorrhoidoplasty procedure (LAH) for the treatment of symptomatic grade ll-lV haemorrhoids.

Eligibility

Sex/Gender
ALL
Age
21 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. between 21-90 years old 2. presents with symptomatic haemorrhoids as evident from clinical assessment 3. never had any haemorrhoid-related operations performed on them before 4. fit for general anaesthesia 5. able to give informed consent 6. willing to be randomized 7. willing to fill in post-operative questionnaires and be compliant to follow up

Exclusion criteria

1. Are pregnant 2. Are prisoners 3. Intellectually, mentally or emotionally deemed not able to provide an informed consent and/or are unable to fill up the post-procedure questionnaires/VAS score 4. Have had previous haemorrhoid procedural treatment before (except Rubber Band Ligation) 5. Declined endoscopic evaluation 6. Are on anti-coagulation 7. Have history of thrombophilia 8. Are on steroids 9. Have haemorrhoids which are incidentally found on endoscopy/clinical examination but are asymptomatic from it

Design outcomes

Primary

MeasureTime frameDescription
Pain scores10 days from opDaily visual analogue pain scale in the first 10 days after surgery. A score of 10 being the worst pain experienced and 1 being no pain experienced.

Secondary

MeasureTime frameDescription
Operative durationduring operationduration of operation
Post-op bleeding10 days from operationincidence of bleeding post op
readmission3 monthsreadmission due to complications
recurrence1 year post operationrecurrence of haemorrhoids or symptoms
Quality of Life measures10 days, 1 month, 3 months and 1 year post operation2 validated questionnaires will be used (\[patient self reported symptoms of haemorrhoids\] Nystrom, et al. and \[standardised haemorrhoidectomy QOL survey\] Chew, et al)

Countries

Singapore

Contacts

Primary ContactFung Joon Foo
foo.fung.joon@singhealth.com.sg+65 6930 5354
Backup ContactFung Joon Foo
foo.fung.joon@singhealth.com.sg+65 6930 6000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026